Skip to main content
. 2022 May 17;12:8224. doi: 10.1038/s41598-022-11020-2

Figure 1.

Figure 1

In vivo drug release from TAF implants in C57BL/6 J mice (N = 3 per timepoint) estimated via residual drug analysis in used devices. Symbols correspond to means ± SEM; solid line, simple linear regression; broken lines, 95% confidence bands. (A) Low-releasing implants; slope = 0.28 ± 0.06 mg d-1; R2 = 0.875. (B) High-releasing implants; slope = 0.58 ± 0.21 mg d-1; R2 = 0.716.